Liposomal Amphotericin B (Ambisome) Versus Oral Voriconazole for the Prevention of Invasive Fungal Infections
Status:
Completed
Trial end date:
2009-10-01
Target enrollment:
Participant gender:
Summary
The goal of this clinical research study is to compare the effectiveness of liposomal
amphotericin B given three times per week , versus liposomal amphotericin B given once per
week, versus oral voriconazole in the prevention of fungal infections in patients with acute
myeloid leukemia (AML) or myelodysplastic syndromes MDS who are receiving chemotherapy. The
safety of these treatments will also be studied and compared.
Phase:
Phase 2
Details
Lead Sponsor:
M.D. Anderson Cancer Center
Treatments:
Amphotericin B Liposomal amphotericin B Voriconazole